<

實驗室成員

 


組長   劉昌邦 醫師

進駐研究醫師:兒童感染科 紀鑫

研究人員

翁麗涓、王乃玉、馮柔安

研究主題

 

成立生物材料資源保存中心,針對檢驗科所分離並鑑定完成的病原株,建制一套資訊化管理模式和訂定生物保全管理規範,可進一步提供臨床醫師於治療方面資訊之所需;並且給予有興趣的研究人員關於檢體樣本資訊之索引,將其推展到院內感染管制層面的實際需求及運用。實驗室之研究特色主要發展脈衝式電泳技術,將其應用於流行性感染疾病之檢測、物種親疏遠近關係之分析、院內群突發感染菌種之監測,建置與疾病管制署同一資訊平台,有利於日後相關資料的比對和確認。病毒研究方向為快速偵測、基因分型與定量分析,探討分子流行病學與親緣關係,瞭解病毒基因型變動及演化情形,提供預防策略的參考。

合作領域

 

疾病與基因相關研究( 國科會計畫:馬偕兒童感染科紀鑫醫師)

研究成果

 

重要研究成果為建置生物材料資源保存中心,保存10年間的細菌株共34368株、病毒株共23241株,提供醫學研究部、檢驗科、小兒部、感染管制中心和感染科等作為臨床及研究使用,亦提供院外單位如疾管署、三軍總醫院、榮民總醫院、國家衛生研究院和彰化基督教醫院等共同研究用。本實驗室利用保存中心之材料,除了確認菌株流行病學相關參數與抗藥性機轉外,也運用DNA圖譜分析軟體(BioNumerics)進行脈衝式電泳(PFGE)結果之比對與鑑識。病毒研究部份,對於小兒呼吸道融合病毒,分子流行病學之親緣關係和基因序列的演化分析亦有完整之探討。

專利

 

可抑制生物膜上金黃色葡萄球菌生長之醫療導管 劉昌邦、王威勝、李聰明,新型第M374340號, 中華民國(台灣) 2010/2/21~2019/9/21

留置型導尿管 劉昌邦、施壽全,新型第M421125號, 中華民國(台灣) 2012/1/21~2021/7/4

代表著作

 

Wu AY, Chang H, Wang NY, Sun FJ, Liu CP. Clinical and molecular characteristics and risk factors for patients acquiring carbapenemase-producing and non-carbapenemase-producing carbapenem-nonsusceptible-Enterobacterales bacteremia. Journal of Microbiology, Immunology and Infection 2022; 55(6 Pt 2):1229-1238. (SCIE, MICROBIOLOGY) (IF: 10.273, Ranking: 17/136=12.5%)

Liu CP, Leung CH, Kuo CF, Yeh HI. Strategies for minimizing intra-hospital transmission of COVID-19 among health care workers in a hospital setting during a COVID-19 pandemic. International Journal of Gerontology. (Accepted) (SCIE, GERIATRICS & GERONTOLOGY) (IF: 0.358, Ranking: 54/54=100%) 

Chang FC, Liu CP, Sun FJ, Lin CC. Optimizing laboratory workflow for the diagnosis of Clostridiodes difficile infection in a medical center in Northern Taiwan. Journal of Microbiology, Immunology and Infection 2021; 54(2):284-289. (SCIE, MICROBIOLOGY) (IF: 10.273, Ranking: 17/136=12.5%)

Chin CY, Liu CP, Wang CL. Evolving public behavior and attitudes towards COVID-19 and face masks in Taiwan: A social media study. PLoS One 2021; 16(5):e0251845. (SCIE, MULTIDISCIPLINARY SCIENCES) (IF: 3.752, Ranking: 29/73=39.7%)

Liu CP, Chiang TT, Liu YM, Kuo SC, Yang YS, Lee YT, Chen TL, Shih SC; ACTION Study Group. A multicenter study on clinical characteristics of acinetobacter bacteremia in patients with liver cirrhosis. Journal of Microbiology, Immunology and Infection 2019; 52(6):956-965. (SCIE, MICROBIOLOGY) (IF: 10.273, Ranking: 17/136=12.5%)

Leung CH, Liu CP. Diabetic status and the relationship of blood glucose to mortality in adults with carbapenem-resistant Acinetobacter baumannii complex bacteremia. Journal of Microbiology, Immunology and Infection 2019; 52(4):654-662. (SCIE, MICROBIOLOGY) (IF: 10.273, Ranking: 17/136=12.5%)

Liu CP, Lu HP, Luor T. Observational study of a new strategy and management policy for measles prevention in medical personnel in a hospital setting. BMC Infectious Diseases 2019; 19(1):551. (SCIE, INFECTIOUS DISEASES) (IF: 3.670, Ranking: 60/94=63.8%)

Liu CP, Lu HP, Luor T. Clonal relationship and the association of the ST218 strain harboring blaOXA-72gene to mortality in carbapenem-resistant Acinetobacter baumannii bacteremia. Journal of Microbiology, Immunology and Infection 2019; 52(2):297-303. (SCIE, MICROBIOLOGY) (IF: 10.273, Ranking: 17/136=12.5%)

Wang TH, Leu YS, Wang NY, Liu CP, Yan TR. Prevalence of different carbapenemase genes among carbapenem-resistant Acinetobacter baumannii blood isolates in Taiwan. Antimicrobial Resistance and Infection Control 2018; 7:123. (SCIE, PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH) (IF: 6.459, Ranking: 38/210=18.1%)

Liu LH, Wang NY, Wu AY, Lin CC, Lee CM, Liu CP. Citrobacter freundii bacteremia: risk factors of mortality and prevalence of resistance genes. Journal of Microbiology, Immunology and Infection 2018; 51(4):565-572. (SCIE, MICROBIOLOGY) (IF: 10.273, Ranking: 17/136=12.5%)